Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Ferlay J(2019)An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values Appl Health Econ Health Policy 17 295-313

[3] Soerjomataram I(2007)Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer Health Qual Life Outcomes 5 70-292

[4] Siegel RL(2002)The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 271-1067

[5] Torre LA(2014)Validation and comparison of EuroQoL-5 dimension (EQ-5D) and short form-6 dimension (SF-6D) among stable angina patients Health Qual Life Outcomes 12 156-1042

[6] Jemal A(2015)The psychometric performance of generic preference-based measures for patients with pressure ulcers Health Qual Life Outcomes 13 117-884

[7] Mukuria C(2003)An empirical comparison of EQ-5D and SF-6D in liver transplant patients Health Econ 12 1061-565

[8] Rowen D(2008)How consistent are health utility values? Qual Life Res 17 1031-986

[9] Harnan S(2004)A comparison of the EQ-5D and SF-6D across seven patient groups Health Econ 13 873-3803

[10] Rawdin A(2020)Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2 Med Care 58 557-12

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Ferlay J(2019)An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values Appl Health Econ Health Policy 17 295-313

[3] Soerjomataram I(2007)Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer Health Qual Life Outcomes 5 70-292

[4] Siegel RL(2002)The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 271-1067

[5] Torre LA(2014)Validation and comparison of EuroQoL-5 dimension (EQ-5D) and short form-6 dimension (SF-6D) among stable angina patients Health Qual Life Outcomes 12 156-1042

[6] Jemal A(2015)The psychometric performance of generic preference-based measures for patients with pressure ulcers Health Qual Life Outcomes 13 117-884

[7] Mukuria C(2003)An empirical comparison of EQ-5D and SF-6D in liver transplant patients Health Econ 12 1061-565

[8] Rowen D(2008)How consistent are health utility values? Qual Life Res 17 1031-986

[9] Harnan S(2004)A comparison of the EQ-5D and SF-6D across seven patient groups Health Econ 13 873-3803

[10] Rawdin A(2020)Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2 Med Care 58 557-12